#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal squamous cell carcinoma stage III Immune-mediated myositis HER2 gene amplification Interstitial lung disease Anti-glomerular basement membrane disease Arteriovenous malformation Mitochondrial DNA depletion Cutaneous calcification Neovascular age-related macular degeneration Cervix carcinoma Cutaneous T-cell lymphoma stage I Prolymphocytic leukaemia Dedifferentiated liposarcoma Noonan syndrome Fragile X syndrome More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma metastatic – Treatment Proteus syndrome – Diagnostics Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Indolent systemic mastocytosis – Basic Information Hairy cell leukaemia – Treatment Ehlers-Danlos syndrome – Life with Disease Mantle cell lymphoma stage IV – Basic Information Medulloblastoma recurrent – Basic Information Medulloblastoma Uterine leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nizaracianine Triflutate Alx148 Imifoplatin Naloxone Hydrochloride 68Ganota-Anti-Her2 Vhh1 Aptamer-4Ft Tamsulosin Hydrochloride Sufentanil Sqy51 L-Lysine Acetate PETHIDINE HYDROCHLORIDE TRV045 Vibosameran Ambroxol Hydrochloride Fadraciclib Donanemab Amitriptyline Hydrochloride Febuxostat Hemihydrate Magnesium Hydroxide Eo2318 More therapies…

    Learn about Your Condition

    White matter lesion Vulvovaginal dryness Obliterative bronchiolitis Laparotomy Systemic candida Anal cancer recurrent Essential hypertension Compulsive sexual behaviour Crigler-Najjar syndrome Basal cell naevus syndrome Diabetes mellitus Hypogonadism male Hypotransferrinaemia Ependymoma malignant Hepatitis B More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study on Estradiol for Treating Anorexia Nervosa in Adolescent Girls

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Anorexia nervosa
    Investigated Drugs:
    • Estradiol
    Norway

  • Study on the Effects of Sertraline on Anxiety and Depression in Heart Failure Patients with Preserved Ejection Fraction

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Anxiety
    • Heart failure with preserved ejection fraction
    • Depression
    Investigated Drugs:
    • Sertraline
    Poland

  • Study on Stopping Antidepressants: Comparing Tapering Methods for Patients with Major Depressive Disorder Using Venlafaxine or Paroxetine Hydrochloride

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Paroxetine Hydrochloride
    • Venlafaxine
    The Netherlands

  • Study on Continuing or Reducing Antipsychotic Medication (Haloperidol, Clozapine, Tiapride) for Patients After First Episode of Psychosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psychotic behaviour
    • Psychotic disorder
    Investigated Drugs:
    • Chlorpromazine
    • Haloperidol
    • Pimozide
    The Netherlands

  • Study on Cannabidiol for Reducing Alcohol Consumption in Patients with Alcohol Use Disorder

    Not recruiting

    2 1
    Investigated Diseases:
    • Alcoholism
    Investigated Drugs:
    • Cannabidiol
    France

  • Study on Hydrocortisone and Food Exposure Therapy for Patients with Binge Eating Disorder

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Binge eating
    Investigated Drugs:
    • Hydrocortisone
    Germany
Previous Page
1 … 30 31 32 33 34 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!